The legacy of Viagra and the medicinal industry presents a challenging picture for careful investors. Initially, copyright's hugely successful drug revolutionized the treatment of erectile dysfunction, producing substantial profits and shaping the current pharmaceutical landscape. However, exclusive rights expiration and the emergence of generic ve